Casneuf, T., Axel, A. E., King, P., Alvarez, J. D., Werbeck, J. L., Verhulst, T., . . . Sasser, A. K. (2016). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer (Dove Med Press).
Citação norma ChicagoCasneuf, Tineke, Amy E. Axel, Peter King, John D. Alvarez, Jillian L. Werbeck, Tinne Verhulst, Karin Verstraeten, Brett M. Hall, and A Kate Sasser. "Interleukin-6 Is a Potential Therapeutic Target in Interleukin-6 Dependent, Estrogen Receptor-α-positive Breast Cancer." Breast Cancer (Dove Med Press) 2016.
MLA CitationCasneuf, Tineke, et al. "Interleukin-6 Is a Potential Therapeutic Target in Interleukin-6 Dependent, Estrogen Receptor-α-positive Breast Cancer." Breast Cancer (Dove Med Press) 2016.